Company: ALCE
Filing Date: 2025-01-27
Form Type: S-1
Source: 0001213900-25-007054
Chunk: 308

Company: Alternus Clean Energy, Inc.
Filing Date: 2025-01-27
Form: S-1
Chunk 308
---
es, transferees or their respective successors-in-interest in a private placement transaction that closed on January 23, 2025 (the “Private Placement”). Any Selling Stockholder may sell all or a portion of these shares from time to time in market transactions through any market on which the Common Stock is then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined by the then prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal or by a combination of such methods of sale. The Selling Stockholders will receive all proceeds from such sales of the Bridge Warrant Shares. For additional information on the methods of sale of the Bridge Warrant Shares, you should refer to the section entitled “Plan of Distribution.” We will not receive any proceeds from the sale of shares by the Selling Stockholders, other than any proceeds from any cash exercise of Bridge Warrants, if any. The distribution of securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers’ transactions, privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals. Usual and customary or specifically negotiated brokerage fees or commissions may be paid by the Selling Stockholders. On _____, 2025, a registration statement under the Securities Act of 1933, as amended (the “Securities Act”) with respect to our public offering (the “Primary Offering”) of units was declared effective by the Securities and Exchange Commission (the “SEC”). We received approximately $_______million in net proceeds from the offering after payment of placement agent discounts and commissions and estimated expenses of the offering. Investing in our common stock involves a high degree of risk, including the risk of losing your entire investment. See “ Risk Factors” beginning on page 4 of the primary offering prospectus contained in the registration statement of which this prospectus forms a part, to read about factors you should consider before buying our common stock. Neither the SEC nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. The date of this prospectus is __________, 2025 TABLE OF CONTENTS

|                      | Page  |
| THE OFFERING         | Alt-1 |
| USE OF PROCEEDS      | Alt-2 |
| SELLING STOCKHOLDERS | Alt-3 |
| PLAN OF DISTRIBUTION |